Selective Inhibitors of a Human Prolyl Hydroxylase (OGFOD1) Involved in Ribosomal Decoding
作者:Cyrille C. Thinnes、Christopher T. Lohans、Martine I. Abboud、Tzu‐Lan Yeh、Anthony Tumber、Radosław P. Nowak、Martin Attwood、Matthew E. Cockman、Udo Oppermann、Christoph Loenarz、Christopher J. Schofield
DOI:10.1002/chem.201804790
日期:2019.2.6
Human prolyl hydroxylases are involved in the modification of transcription factors, procollagen, and ribosomal proteins, and are current medicinal chemistry targets. To date, there are few reports on inhibitors selective for the different types of prolyl hydroxylases. We report a structurally informed template-based strategy for the development of inhibitors selective for the human ribosomal prolyl
人脯氨酰羟化酶参与转录因子,前胶原蛋白和核糖体蛋白的修饰,并且是当前的药物化学靶标。迄今为止,很少有关于对不同类型的脯氨酰羟化酶具有选择性的抑制剂的报道。我们报告了结构选择性的抑制剂为人类核糖体脯氨酰羟化酶OGFOD1选择性抑制剂发展的基于模板的策略。这些抑制剂未针对其他测试的人类加氧酶,包括结构相似的低氧诱导转录因子脯氨酰羟化酶PHD2。